llC]-Carfentanil is a high affinity opiate ago nist that can be used to localize mu opiate receptors in humans by positron emission tomography (PET). A four compartment model was used to obtain quantitative esti mates of rate constants for receptor association and dis sociation. PET studies were performed in five normal subjects in the absence and presence of 1 mg/kg nalox one. Arterial plasma concentration of P lC]-carfentanil and its labeled metabolites were determined during each PET study. The value of k3/k4 = Bmax/kD was determined for each subject in the presence and absence of naloxone. There was a significant reduction in the value of k3/k4 from 3.4 ± 0.92 to 0.26 ± 0.13 in the thalamus (p < 0.01) and from 1.8 ± 0.33 to 0.16 ± 0.065 in the frontal cortex (p < 0.001). Mean values of frontal cortex/occipital cor tex and thalamus/occipital cortex ratios were determined for the interval 35-70 min after injection when receptor binding is high relative to nonspecific binding. The re1a-Opiate receptors and endogenous opioid peptides comprise a major neurochemical system with roles in pain, Abbreviations used: PET, positron emission tomography; CT, computed tomography; RMS, root mean square; AIC, Akaike information criterion; HPLC, high performance liquid chroma tography.
agonist, has been used to localize mu opiate recep tors in humans by positron emission tomography (PET) and to identify increases in mu opiate recep tors in patients with partial complex epilepsy (Frost et aI., 1985; . Drugs labeled with positron emitting isotopes have also been used to localize and quantitate dopamine, serotonin, benzodiaze pine, and other receptors (Frost, 1986; Frost et aI., 1986; Persson et aI., 1985; Wagner et aI., 1983; Farde et aI., 1986; Maziere et aI., 1985; Smith et aI., 1988) . 398 A primary goal of these studies is to apply tracer kinetic modeling to the estimation of receptor num ber and rate constants for receptor binding that are independent of nonspecific processes such as blood flow or blood-brain transport. This study describes the use of tracer kinetic modeling to quantify [1lC]-carfentanil binding to mu opiate receptors in humans as well as simulation studies that demon strate the theoretical behavior of the model when receptor and nonreceptor perturbations are intro duced. Tracer kinetic modeling has been applied previously in other systems to quantify receptor binding in vivo in human and nonhuman studies (Farde et aI., 1986; Wong et aI., 1986a Wong et aI., , 1986b Lo gan et aI., 1987; Bice and Zeeberg, 1987; Frey et aI., 1985; Patlak and Blasberg, 1985; Mintun et aI., 1984; Frost and Wagner, 1984; Perlmutter et aI., 1986) . Equilibrium and nonequilibrium models have been employed with various levels of simplifying assumptions that have not always been validated. It was a primary goal of this study to use the most complete tracer kinetic approach justified by the data and subsequently utilize simulation experi ments to determine when simplified methods of quantification could be employed.
METHODS

Data acquisition
Four healthy males (ages 18 to 42 years) and one female (age 21 years) were recruited by advertisement. These subjects had no history of ingestion of opiates or other drugs and no history of psychiatric or neurological disor ders. All patients gave informed consent prior to the PET studies.
X-ray computed tomography (CT) was used prior to the PET study to identify an imaging plane parallel to the glabellar-inion line and passing through the center of the thalamus, a structure containing high levels of mu opiate receptors (Pfeiffer et aI., 1982) . This imaging plane also passed through the occipital cortex, which contains neg ligible levels of opiate receptors (Pfeiffer et aI., 1982) . Two additional planes 32 mm above and below the middle plane included the temporal lobes, cerebellum, and ros tral cerebral cortex. A thermoplastic face mask with an alignment line drawn at the time of the CT scan was used to insure reproducible positioning between the CT and PET scans. PET studies were performed using the Neu roECAT scanner operating in the high resolution mode (Hoffman et aI., 1983) .
Subjects were studied in the absence and presence of I mg/kg intravenous naloxone, an opiate antagonist, admin istered 5 min before [llC]-carfentanii. Previous studies (J. J. Frost, unpublished) demonstrate that 0.1 mg/kg in travenous naloxone is sufficient to inhibit completely [llC]-carfentanil binding. A dose of 1.0 mg/kg was used to insure complete blockade of opiate receptors for the du ration of the study. The results of these studies were used to estimate nonspecific binding parameters in various brain regions. Approximately 20 mCi (4.6 to 6.9 fLg) of [ II C]-carfentanil was administered in each study. PET data was acquired beginning 30 s after [llC]-carfentanil administration according to the following protocol: three 2 min scans, three 3 min scans, five 6 min scans, two II min scans, and one 21 min scan. The study with naloxone was performed 3 h after the study with [llC]-carfentanil alone.
A radial artery catheter was placed in order to collect blood samples for determination of the kinetics of total plasma radioactivity and the percent of the total arterial radioactivity represented by nonmetabolized [ I I C] _ carfentanii. Total plasma radioactivity was measured ac cording to the following sampling protocol: 5 s intervals for the first 2 min, I min intervals up to 10 min, 2 min intervals up to 20 min, and 5-15 min intervals up to 90 min postinjection. Arterial samples (10 ml) were also collected for determination of plasma metabolites using high per formance liquid chromatography (HPLC) at 1, 5, 10, 15, 30, 45, 60 , and 90 min after [ II C]-carfentanil injection.
Activity was isolated from plasma prior to HPLC anal ysis. Two C-18 SEP-PAKs (Waters Associates, Milford, MA, U.S.A.) in series were activated with 5 ml of meth anol and subsequently flushed with 10 ml of O.IM ammo nium formate buffer. Plasma was isolated from 10 ml blood samples collected in heparinized tubes, passed slowly through the SEP-PAKs, and followed by 10 ml of buffer to wash through residual proteins. The heparinized collection tubes contained carfentanil at final concentra tion of 10 fLM to act as a carrier. Greater than 95% of the total plasma radioactivity was retained on the SEP-PAKs using this procedure. The radioactivity was then eluted off the SEP-PAKs using 1.5 ml of methanol followed by a bolus of air. Greater than 95% of the radioactivity on the SEP-PAKs was eluted with this procedure. Ammonium formate buffer was then added to the methanol to reach a composition equal to the mobile phase used during the HPLC analysis (75% methanol with O.IM ammonium formate/25% O.IM ammonium formate buffer). All sepa ration procedures were performed using ice-cold solu tions and materials. Control studies in which e1C] carfentanil was added directly to blood samples demon strated that no metabolism or degradation occurred during the period necessary to complete the above pro cedure.
Two milliliters of the methanolfbuffer solution contain ing the isolated plasma radioactivity was injected onto a C-18 reverse phase analytical column (Waters Associ ates). The mobile phase was methanol with O.IM ammo nium formate and O.IM ammonium formate buffer in ap proximate proportions of 75/25 at a flow rate of 2 mllmin. The eluent was passed through a UV detector and sub sequently through a 1 ml loop positioned between two opposing 5 in. NaI(Tl) detectors that were peaked to de tect 511 keY photons in a singles mode. The rate meter signal was fed to a strip chart recorder with an automatic integration feature (Waters Associates) and the area un der each radioactive peak was calculated. The area of each peak was decay corrected to the time of sample injection and from this data the percent of the total activ ity represented by [llC]-carfentanil was determined.
Calibration of the PET scanner and the well scintilla tion detector for counting blood samples was accom plished using a 20 cm cylindrical phantom containing a known concentration of 18F. Calibrated samples from the phantom were also counted in the well counter. Calibra tion data, together with the measured specific activity of p1C]-carfentanil at the time of injection, was used to ex press blood and PET data in nM units.
All PET images were corrected for attenuation using a calculational method with an average brain attenuation coefficient. Images were summed from 35-70 min after injection to enhance anatomic detail for region of interest (ROI) placement. ROIs were drawn on the right and left thalamus, regions of the right and left frontal cortex in the most rostral plane, and medial occipital cortex. Right and left values for each structure were averaged for subse quent analysis. These ROIs were then transferred to the images obtained at each time point as mentioned above. The ROIs from the study using [ II C]-carfentanil alone were transferred to the studies in which I mglkg of nal oxone was used since these images showed little ana tomic detail (Frost et aI., 1985) .
Theoretical and data analysis
The kinetics of brain [ II C]-carfentanil in thalamus and occipital cortex was modeled using the four compart ments shown in Fig. 1 . The model consists of a vascular compartment and three tissue compartments that corre spond to free tracer, non-specifically bound tracer, and receptor bound tracer. Six rate constants were used to model tracer uptake in receptor-rich regions such as the thalamus and frontal cortex. The constants are KI and k2 for transport into and out of the tissue space, respec tively, k3 and k4 for binding to and dissociation from re ceptors, respectively, and ks and k6 for binding to and dissociation from the nonspecific compartment, respec tively. In a region such as the occipital cortex that has a negligible concentration of opiate receptors, k3 and k4 were set to zero. If plasma and brain concentrations are expressed in units of nM, the KI will have units of mil minlml of brain tissue and k2 through k6 have units of min-I .
is
The set of differential equations describing this model
(3)
where C;(t) is the concentration in each compartment and C(t) represents the model solution that will be compared to the observed activity within the brain measured by PET.
The analytical solution to a system of linear first-order
�K'
PLASMA ---. C,
FIG. 1. Schematic representation of the four-compartment model. e 1 represents the mean capillary plasma concentra tion. The tissue compartments are extracellular free tracer (e2), non-specifically bound tracer (e/2), and receptor bound tracer (e3). The constants K 1 -ks are the first-order rate con stants for transport of tracer among the compartments.
J Cereb Blood Flow Me t ab, Vol. 9, No. 3, 1989 differential equations with constant coefficients may be expressed as the convolution of the input function, which in this case is C1(t), with a sum of exponential terms. The number of terms in the sum is equal to the number of observed compartments in the model. This solution may be written as
The coefficients Lj and rates Rj are calculated from the model equations and are functions of the rate constants KI-k6• The dependence of the Lj and Rj on the K; is de termined by the arrangement of the compartments in 
The transfer rate k3 into the receptor bound compart ment is treated as a first-order rate constant. This pre supposes that the concentration in this compartment C3 is always negligible compared to the total concentration of receptors Brnax. In this approximation, k3 equals the prod uct (kon)(Brnax), where kon is the molecular association rate constant. The dissociation rate constant k4 depends on the molecular dissociation rate constant k O ff' modified by processes such as receptor rebinding (Frost and Wag ner, 1984) .
Since capillaries contain metabolized as well as unme tabolized caIfentanil, the volume of blood within the PET region of interest contributes to the observed PET count rate in proportion to the total count rate for whole blood. Thus, a small percentage «10%) of the total blood activ ity could be subtracted from the PET data to correct for blood volume effects, if necessary. The model fit should be optimal when the correct percentage has been sub tracted. Therefore, the model equations are used only to calculate the tissue concentration C(t). This was then compared with the observed regional kinetics, which was adjusted by the subtraction of blood activity. Various per centages (2-8%) of the total blood concentration of [11C]-caIfentanil and metabolites was subtracted from the regional concentration determined by PET and the effect of this on the model fit was evaluated.
The concentration C I in the vascular compartment, which drives the differential equations, may be taken to be equal to the average capillary concentration. As shown by Gjedde (1982) , when this is calculated for constant flow and bidirectional diffusion, the form of the the model equations is unchanged. The arterial plasma concentra tion Cp(t) may be used for C1, with K I and k2 redefined to include the effects of flow and diffusion (Frey et al., 1985) .
The model function C(t) was calculated as a sum of convolution integrals determined by the parameters K 1 -k6 and the input function CpU) [Eqs. (4)- (9)]. This was compared to the measured regional PET activity and op timal values of the model parameters were obtained by a Marquardt nonlinear least squares minimization proce dure. This method provides rapid convergence to a set of parameters that was essentially independent of the initial estimates of these parameters in the absence of naloxone.
In the presence of naloxone, k3 and k3/k4 were fit to the data in order to reduce the uncertainty in k3/k4' Compar isons between fits obtained with varying numbers of data points and parameters were made with both the root mean-square (RMS) error, and the Akaike information criterion (AIC) (Carson et al., 1983) . The results of the RMS error and AIC agreed in every case. The differences between methods were generally more pronounced with the AIC so only these results will be given. The AIC was defined as AIC = -n In(SSQ) -2p, where n = number of data points, SSQ = sum of squared errors, and p = number of parameters. This equation is the inverse of the usual definition so that the values are positive, with larger values denoting a better fit. The input function CpU) was calculated from the mea sured plasma activity by linear interpolation between data points. The measured metabolite percentages were also interpolated linearly and multiplied by the total plasma activity to obtain the plasma kinetics of [ II C]-caIfentanil. For times after the end of blood sampling, the plasma curve was extrapolated linearly with a slope equal to the average of the last four measured intervals. This was nec essary in only 1 of the 10 studies analyzed when a few blood samples prior to the end of the PET acquisition were lost.
To simulate the empirical average thalamus/occipital cortex ratio, the model thalamus/occipital cortex ratio was calculated at 30, 45, 60, and 75 min. This was done first using the optimal parameters determined by the least squares fit to the data. The average of the ratios calcu lated at these time points was recorded as the model av erage thalamus/occipital cortex ratio. Then both k3 and k4
were varied systematically by factors of 2 and the ratio calculated again. The ratios were plotted for the five sub jects for a constant value of k4 while k3 was varied. In this model, K I and k2 both depend on flow, but their ratio is independent of flow. The effect of changing flow to the thalamus was simulated by calculating the diffusion rate (effective permeability -s suIface area) from the optimal value of K I (for each subject) and a measured average flow rate (56 ml/min/IOO g) (P. T. Fox, personal commu nication). For different flow rates, new values of K I and k2 were computed and used to generate curves of thala mus/occipital cortex vs. time. These curves were aver aged for 35 to 70 min to estimate the change in the thal amus/occipital cortex ratio as a function of blood flow.
RESULTS
The analysis of [IIC]-carfentanil metabolism in the absence of naloxone for the five subjects is shown in Fig. 2 . Inspection of the HPLC chromato grams demonstrates a primary labeled metabolite of ["C]-carfentanil that migrates as a significantly more polar substance on the C-18 column (data not shown). There are also a few small peaks migrating close to the predominant metabolite that comprise 5-10% of the total activity. The percent metabolites in the presence of naloxone was in each subject 10--15% greater than without naloxone (data not shown). An example of the measured plasma radio activity and the corresponding metabolite-corrected curve for one subject in the absence of naloxone is [11C]-Carfentanil metabolism in the presence of 1 mgt kg of naloxone was 10-15% greater than in its absence after 30 min (data not shown).
shown in Fig. 3 . Whereas the total plasma radioac tivity is nearly constant from 15-90 min after injec tion, the concentration of nonmetabolized carfenta nil decreases significantly during this time interval. A similar pattern was observed in other individuals with and without naloxone. Figure 4 demonstrates the fit of the occipital cor tex data in the absence of naloxone by both a two and three-compartment model. The metabolite corrected [llC]-carfentanil plasma curve was used for each of these fits. The two-compartment model combines the brain free and non-specifically bound activities (C2 and C' 2) into a single compartment, whereas the three-compartment model treats free and non-specifically bound activity separately. In both cases, receptor binding is absent and therefore k3 = 0 and k4 = O. The fit of the data is significantly better in the occipital cortex and thalamus when the three-compartment model is applied. The AIC im proved from 53 ± 10 to 78 ± 8 (p < 0.0 1, paired t test) when the three-compartment (four-parameter) model was used instead of the two-compartment (two-parameter) model in the prenaloxone occipital cortex data. Combining results from pre-and post naloxone studies (occipital cortex only), the AIC improved from 55 ± 14 to 83 ± 18 (p < 0.0 1, n = 10). This result suggests that the free and non specifically bound e IC]-carfentanil may not be in rapid equilibrium and thus can be kinetically sepa rated. Therefore, in a region that contains unoccu pied receptors, a four-compartment model is appro priate.
Figures 5 and 6 demonstrate the effect of correct ing the plasma data for e IC]-carfentanil metabolism on the model. Figure 5 shows the thalamus and oc cipital cortex data for one subject with the model function calculated using three compartments and uncorrected plasma data. Figure 6 shows the same data with the model functions calculated using the metabolite-corrected plasma curve; in this figure, three compartments were used for the occipital cor tex and four compartments for the thalamus. The fit to the data by the model for both the thalamus and occipital cortex was significantly improved when metabolite-corrected plasma curves were used. When total plasma activity was used as the input function, model curves consistently overestimated (0) and occipital cortex (e) compared to non-metabolite corrected plasma activity (Fig. 5 ). The Ale parameter im proved from 61 ± 18 to 72 ± 19 (p < 0.05) in the thalamus and from 67 ± 22 to 87 ± 18 (p < 0.01) in the occipital cortex when metabolite-corrected plasma curves were employed.
the PET data after about 20 min. This overestima tion occurred regardless of the number of compart ments used for both thalamus and occipital cortex. The Ale parameter improved from 61 ± 18 to 72 ± 19 (p < 0. 05, n = 5, prenaloxone) and from 73 ± 23 to 82 ± 20 (p < 0. 02, n = 5, postnaloxone) in the thalamus and from 67 ± 22 to 87 ± 18 (p < 0. 01, n = 10) in the occipital cortex by use of metabolite corrected plasma curves. Similar fits were attempted following subtraction of 2-8% of the total blood concentration of [l1C]-carfentanil and its labeled metabolites in order to evaluate possible effects of the finite brain blood volume. This procedure produced a small improve ment in the fit in one subject and worse or singular fits in the others. Accordingly, all rate constants in Tables 1 and 2 were computed without blood vol ume corrections. Table 1 shows the individual rate constants and mean values in the occipital cortex, thalamus, and frontal cortex for five normal volunteers. The val ues of ks and k6 were determined in the occipital cortex and subsequently used in the analysis of frontal cortex and thalamus kinetics. Values of k31k4 were also determined by treating k3 and k31k4 as a fitting parameter for comparison to values in Table   2 . Similar values of kik4 were determined for both methods. The mean value of the binding potential (Bmax l KD = kik4) (Mint un et aI., 1984) was 1. 8 in the frontal cortex and 3.4 in the thalamus, commen surate with the lower density of mu opiate receptors in the frontal cortex (Pfeiffer et aI., 1982) . Similar values of k3 and k4 were obtained when k5 and k6
were allowed to vary during the fitting procedure but the statistical uncertainty in k3 and k4 was much greater (data not shown). The parameter estimates were insensitive to the initial values of the param eters; starting values were increased and decreased by up to a factor of 10 without altering the final estimates. Table 2 shows the rate constant values for the same five normal subjects in similar studies con ducted following intravenous administration of 1 mg/kg of naloxone. Five of 10 fits became singular after two to three iterations with very uncertain val ues of k3 and k4 since 1 mg/kg of naloxone results in near total inhibition of specific [llC]-carfentanil binding (Frost et aI., 1985) . To overcome this diffi culty, the model fits were performed by selecting J Cereb Blood Flow Metab, Vol. 9, No. 3, 1989 the variables as k3 and k3/k4' Under these condi tions, less uncertain estimates of k3/k4 could be ob tained. There was significant reduction in the value of k3/k4 from 3.4 ± 0. 92 to 0.26 ± 0. 13 in the thal amus (p < 0. 01) and from 1. 8 ± 0. 33 to 0. 16 ± 0. 065 in the frontal cortex (p < 0. 001). There were no significant differences in the values of K1, k2' k5' or k6 in the presence and absence of naloxone. Results from studies performed in the absence of naloxone demonstrated smaller errors in model fits when only k3/k4 was varied, but the values of kik4 were com parable to results obtained when k3 and k4 were varied independently in all of the five subjects (data not shown). Figure 7 shows the relationship between mea sured frontal cortex and thalamus to occipital cor tex ratios and corresponding kik4 values for five subjects in the presence and absence of naloxone. Mean values of thalamus/occipital cortex or frontal cortex/occipital cortex were determined for the in terval As the value of k:Jk4 is increased or decreased, thalamus/ occipital cortex changes accordingly for times later than 30 min. For earlier times, the change is much smaller since the specific binding is low. For very large values of k3/k4 (curve farthest left), the thalamus/occipital cortex increases linearly as a function of time due to irreversible binding. Similar re sults were observed in the other four subjects.
simulated by recomputing the model output func tion. By systematically varying one parameter at a time and plotting the computed model curve, it was possible to show graphically the effect of changes in various parameters on the output values. Figure 8 shows the effect of simulated changes in k3/k4 in the thalamus on the ratio of thalamus/ occipital cortex concentrations as a function of time. These results were obtained when k3/k4 was changed by varying k3; similar results were obtained by varying k4• There is little change in the thalamus/ occipital cortex ratio at early times for different val ues of kik4. However, at times later than 20 min, when receptor binding predominates, there is a large effect on the value of thalamus/occipital cor tex as k3/k4 is varied. As k3/k4 approaches 0, the thalamus/occipital cortex ratio remains constant at a value near unity. At large values of k3/k4' the in crease in thalamus/occipital cortex becomes pro gressively smaller for a constant increase in k3/k4' To explore further this relationship, the average value of the thalamus/occipital cortex ratio over the time interval of 35-70 min was computed as a func-. tion of simulated values of kik4. During this time interval, receptor binding is high relative to nonspe cific binding. There was an approximately linear re lationship between thalamus/occipital cortex and k3/ k4 for values of k3/ k4 less than approximately four times the optimum fit value in each subject (Frost et al., 1988) . At larger values of k3/k4' the value of the thalamus/occipital cortex ratio becomes less sensi tive to changes in kik4. The results were similar when kik4 was varied by changing k4. Similar re sults were obtained in the frontal cortex. Figure 9 shows the results of simulation studies in which blood flow was varied. Blood flow was in creased in the thalamus by a factor of 2 and de creased by a factor of 4 and 16. The resultant thal amus/occipital cortex kinetics for these three con ditions are shown together with the best-fit curve in Fig. 10 . There is no significant difference between the mean value of the curves for 35-70 min for a twofold increase or a fourfold decrease in thalamic blood flow. However, a 16-fold reduction in blood flow significantly reduces the value of thalamus/ occipital cortex. These results demonstrate that specific binding of [llC]-carfentanil at 35-70 min is largely insensitive to changes in blood flow.
DISCUSSION
The results of these studies demonstrate that quantitative estimates of in vivo rate constants for mu opiate receptor binding can be determined using [IlC]-carfentanil and PET. Rigorous multicompart mental parameter estimation can be used to deter-mine the validity of more simple approaches to quantification (i.e., ratios among different regions). The sensitivity of the multi compartmental model to receptor and nonreceptor (e.g., blood flow) changes can be determined through simulation studies.
The average ± SD values for k31k4 = Bmax l Kn for the five normal subjects were 3.4 ± 0.92 and 1.8 ± 0.33 for thalamus and frontal cortex, respectively. These values were determined from the individual estimates of k3 and k4 in Table 1 and are slightly different from the direct determination of kik4. The subjects were heterogeneous with respect to both age and sex, possibly accounting for some of the variation observed between subjects. Preliminary in vitro binding studies in human tissue using eHl-carfentanil have been performed (M. Titeler, Albany State Medical College). The Kn of opiate agonists is sensitive to sodium ion and GTP (Frost and Wagner, 1984) and therefore studies were per formed in the absence and presence of 140 mM NaCI and 10-5 M GppNHp (a nonmetabolized an alogue of GTP) in thalamus and frontal cortex. The in vitro values of BmaxlKn were 8.3 and 3.3 in thal amus and frontal cortex, respectively, in the pres ence of NaCI and GppNHp. In the absence of NaCI and GppNHp, the values were 129 and 54 for thal amus and frontal cortex, respectively. Thus, the in vivo values of kik4 agree more closely with in vitro values of BmaxlKn in the presence of GppNHp and NaCl.
These results correlate with previous in vivo binding results in laboratory animals using a series of [ 3 Hl-opiate ligands demonstrating a significantly better correspondence between in vitro and in vivo results when K n values were measured in the pres ence of GppNHp and NaCI (Frost and Wagner, 1984) . In vivo mu opiate receptors appear to exist in low affinity states possibly due to modulation by endogenous substances such as sodium ion and GTP. Other modulatory substances may act to re duce further the affinity of mu opiate receptors for agonists in humans, accounting for the differences in in vivo and in vitro values of BmaxlKn. Plasma protein binding was not determined in these studies; the effect of protein binding would be primarily to alter K) and produce small effects on k3• Alterna tively, occupation of mu opiate receptors in vivo by endogenous opioids could also account for the lower values of Bmax l Kn observed in vivo. Recov ery coefficient effects may also be responsible in part for the lower values of k31k4 observed in vivo (Hoffman et aI., 1979) . The application of multi compartmental analysis to [IIC]-carfentanil binding employed the fewest number of assumptions that was feasible. Further simplifications in the model were made only after determining their effect on the more complete model. The following addresses the major assump tions used in the analysis of the experimental data.
The form of Eqs. (1) and (3) implies that the spe cifically bound ligand does not occupy a significant fraction of total mu opiate receptors and thus the equations remain linear with respect to receptor number. This simplifies the estimation of rate con stant values, but does not permit independent esti mates of receptor number and the molecular asso ciation rate constant. The assumption can be tested by comparing the maximum specific binding to re ceptor densities determined by in vitro methods (M. Titeler, Albany State Medical College, personal communication). The concentration of specifically bound tracer may be approximated by the differ ence between thalamus or frontal cortex and occip ital cortex ligand concentration. This value was computed as a function of time for each subject . The maximum percent occupancy (i.e., percent of total opiate receptors occupied by carfentanil) in any of the five normal subjects was 5. 1 % (range of 1.5-5.1%) by this analysis and therefore receptor occupation by ligand is not significant under these conditions.
The values of k3 and k4 in thalamus and frontal cortex were estimated with the ratio of K,lk2 held constant at the value determined in the occipital cortex while the individual values of K) and k2 were allowed to vary. The value of K/k2 is equal to the volume of distribution (Vd) (Sokoloff et aI., 1977) . Therefore, this approximation assumes that the vol ume of distribution of [ )) C]-carfentanil is constant for the three gray matter structures that were stud ied. When K ) and k2 were allowed to vary indepen dently while fitting the thalamus and frontal cortex kinetics, significantly smaller values of k3/k4 and k2 were observed, and in one subject the fits became singular. In these model fits, the decrease in the value of k2 increased the value of V d in proportion to the reduction in k3/k4. Therefore, an increase in specific binding may be registered as an increase in k3/k4 or Vd if K ) /k2 does not remain constant. While the assumption of constant K ) /k2 is reasonable for normal subjects, it is possible that Vd may vary in different regions in patients with cerebral pathol ogy. Analysis of occipital cortex data revealed a sig nificantly improved fit to the experimental data when a three-rather than a two-compartment model was employed. One explanation for this result is the existence of a nonspecific binding compartment that turns over relatively slowly due to nonspecific interactions with proteins, lipids, or other nonre ceptor components. Alternatively, one cannot ex clude that this finding is due to the transport of small levels of labeled metabolites into the brain. The presence of small numbers of opiate receptors in the occipital cortex does not appear to explain these results since in vitro studies demonstrate neg ligible concentrations in the occipital cortex and the mean values of k5 and k6 were not significantly dif ferent in the presence and absence of naloxone (Ta bles 1 and 2). If nonzero values of k5 and k6 were due to e ) C]-carfentanil metabolites in brain, then this effect would have been greater in the presence of naloxone since e ) C]-carfentanil metabolism was always greater with 1 mg/kg of naloxone; however, k5 and k6 are similar under both conditions. The application of k5 and k6 determined in the occipital cortex to thalamus and frontal cortex is reasonable since nonspecific interactions are similar in various gray matter structures as demonstrated by in vitro binding assays.
Values of k3/k4 were determined by two methods: fitting k3 and k4 independently and fitting k3 and kik4 as the variables. In the absence of naloxone, the values of k3/k4 were not significantly different, but the statistical uncertainty in kik4 was signifi cantly smaller when fit as a single variable. The similarity of k3/k4 without naloxone determined by the two methods substantiates the stability of the model with respect to independent estimates of k3 and k4• When small levels of specific binding are encountered, as in the case of binding inhibition studies, it becomes increasingly difficult to deter mine accurately k3 and k4 independently. The inhi bition studies represent an extreme case in which it was intended to use a dose of naloxone that would maximally inhibit receptor binding. When k3 and k4 in thalamus and frontal cortex were set to zero, the data and the resultant model curves were very sim ilar. Whenever low levels of receptor binding is en countered, it is preferable to compute k3/k4 accord ing to the above procedure.
Adequate fits to the model in thalamus, frontal cortex, and occipital cortex could be obtained only by correcting the plasma input function for metab olites of [IIC]-carfentanil. Furthermore, the extent of e ) C]-carfentanil metabolism in the absence and presence of naloxone is different, demonstrating the need to determine directly metabolites when recep tor measurements are conducted using multicom partmental analysis during drug administration. The identity of labeled metabolites of [IIC]-carfentanil has not yet been determined, but the metabolites are not the result of simple de methylation (resulting in [IIC]-methanol, formaldehyde, or carbon diox ide) since all labeled metabolites are retained signif icantly by the C-18 reverse phase column and ac tivity in expired air was insignificant when trapped using activated charcoal and sodium hydroxide (data not shown).
Simulation studies were helpful in evaluating the behavior of the model when receptor and nonrecep tor parameters were perturbed. It is not always fea sible or desirable to perform studies suitable for tracer kinetic modeling, e.g., in uncooperative or debilitated patients or when extensive sampling of arterial blood or measurement of metabolites is not possible. Therefore, it is helpful to have simplified methods of quantification available. However, it is critical that such methods be validated with respect to their sensitivity to receptor and nonreceptor pro cesses. Methods utilizing ratios among regions can be validated in part through simulations using data from tracer kinetic modeling studies. Without such validation studies, misleading results may be ob tained with respect to the presence or absence of receptor changes in patient groups, following inhi bition of receptors by drugs, and during physiologic activation.
Simulation studies (Fig. 8 ) in which k3/k4 was sys tematically increased or decreased demonstrated that region/occipital cortex ratios varied in the same direction as k3/k4 particularly at times after 30 min.
At early time points, the variation was much less since the percent of the total activity that is specif ically bound to receptors is relatively low. If a per turbation produces an alteration in receptor bind-ing, then the difference in region/occipital cortex curves will be most evident at these later times.
If k3/k4 is increased to very large values, the close interdependence of region/occipital cortex values and k3/k4 is diminished. This limit corresponds to conditions of irreversible binding, in which case the concentration of tracer ligand may be depleted in the extracellular compartment more rapidly than it is replenished from the circulation; under these con ditions, specific binding is underestimated. This can be seen in Fig. 8 on the left-hand curves, which increase approximately linearly with time. This be havior has been observed in the case of [IIC]_ and eSF]-N-methylspiperone binding to dopamine D2 receptors (Wong et aI., 1986a) . In contrast, [lIC]-carfentanil dissociates from mu opiate recep tors in vivo as demonstrated by the finite values of k4.
[IIC]-Carfentanil achieves near equilibrium with nonreceptor compartments after 30 min as demon strated by the near constant ratios of thalamus/ occipital cortex ( Fig. 8 ) and thalamus/plasma (data not shown). The linear relationship between region/ occipital cortex values and k3/ k4 demonstrated in Fig. 7 was also observed in the simulation studies (Frost et al., 1988) . This approach has been used to quantify asymmetries in e IC]-carfentanil specific binding in patients with unilateral temporal lobe sei zure foci (Frost et al., 1988) .
The effect of blood flow was also evaluated using simulation methods. While large (16-fold) decreases in blood flow resulted in a reduction of the thala mus/occipital cortex ratio ( Fig. 9) , changes well within physiologic limits (a twofold increase or a fourfold decrease) did not significantly change this ratio. This result may be due, in part, to the attain ment of near equilibrium between [IIC]-carfentanil specific binding and plasma activity; under condi tions of equilibrium, kinetic processes such as blood flow determine only the rate at which equi librium is attained. Figure 9 also demonstrates that if large changes in flow exist, the effect on the re gion/occipital cortex curve will predominate at early times as opposed to receptor changes that pre dominate at late times.
The results of this study demonstrate that mu opi ate receptor binding may be quantified by a four compartment model using few assumptions. The model is general enough to be applied to other tracer ligands for the opiate receptor and other re ceptor types. Ratios among different regions have been validated to identify and quantitate changes in mu opiate receptor binding using [lIC]-carfentanii. The sensitivity of this method with respect to changes in blood flow and k3/k4 has been validated. When independent estimates of k3 and k4 are re-J Cereb Blood Flow Metab, Vol. 9, No. 3, 1989 quired, the complete multicompartmental analysis is recommended.
